data_1tmr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tmr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.665 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.67 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 16' ' ' CYS 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.707 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.615 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.646 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.666 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.615 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.866 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HD13 ' A' ' 9' ' ' ILE . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.692 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.667 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.9 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.9 ' HD2' HG22 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.624 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.566 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' ND1' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.527 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 ' NE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.88 ' NE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.775 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.775 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.527 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.729 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB1' ' HD1' ' A' ' 19' ' ' PHE . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' CD ' ' HB3' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.789 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.789 ' HD2' HG22 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.544 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.69 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.93 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.804 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.778 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.93 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.659 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.694 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.694 ' HD2' HG22 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.892 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.684 ' CD1' ' HB2' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.783 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG22 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' O ' HD13 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.945 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.945 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.892 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.683 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.985 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.719 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.751 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' HG22 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG2' HG21 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.995 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.995 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.985 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.0 t -166.55 -124.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.383 -1.448 . . . . 0.0 111.311 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.65 159.58 34.26 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.937 1.695 . . . . 0.0 112.913 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.67 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 16' ' ' CYS 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.707 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.707 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.6 t -165.58 -97.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.939 -1.726 . . . . 0.0 111.58 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.615 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . -127.76 159.28 35.27 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 126.389 1.876 . . . . 0.0 112.106 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.666 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.615 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.866 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HD13 ' A' ' 9' ' ' ILE . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.692 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.3 t -93.31 -86.87 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.95 -1.719 . . . . 0.0 111.876 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.667 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . -144.48 164.69 30.12 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 126.042 1.737 . . . . 0.0 112.558 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.9 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.9 ' HD2' HG22 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.624 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t 69.82 -94.31 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.692 -1.88 . . . . 0.0 111.788 164.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.18 158.72 38.11 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 127.033 2.133 . . . . 0.0 111.953 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.566 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.806 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' ND1' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 11.0 t 78.79 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.637 -1.914 . . . . 0.0 112.0 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 2' ' ' CYS . . . 169.49 147.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.653 1.581 . . . . 0.0 112.953 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.527 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.88 HD11 ' NE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.88 ' NE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.775 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.775 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.498 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 9.2 t 50.65 -98.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.61 -1.931 . . . . 0.0 111.215 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . 169.04 158.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.801 1.64 . . . . 0.0 113.046 -173.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.779 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.729 ' CG ' ' HB2' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB1' ' HD1' ' A' ' 19' ' ' PHE . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' CD ' ' HB3' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.789 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.789 ' HD2' HG22 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.618 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 t -169.29 -96.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.073 -1.642 . . . . 0.0 112.176 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.544 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . . . -129.12 157.71 40.99 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 126.492 1.917 . . . . 0.0 112.141 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.93 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.804 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.778 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.778 ' HD2' HG22 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.93 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.8 t -159.79 -85.76 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.909 0 O-C-N 119.763 -1.836 . . . . 0.0 112.656 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.63 174.86 11.05 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.073 2.149 . . . . 0.0 112.517 -166.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.659 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.694 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.694 ' HD2' HG22 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.488 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 11.2 t 43.71 -108.85 0.13 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.593 -1.942 . . . . 0.0 112.189 167.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.684 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . 168.41 132.22 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.109 1.763 . . . . 0.0 112.617 -175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.892 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.684 ' CD1' ' HB2' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.783 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG22 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' O ' HD13 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.945 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.945 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.892 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t 52.33 -94.48 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.816 0 O-C-N 119.686 -1.884 . . . . 0.0 112.192 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.89 3.44 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.783 1.633 . . . . 0.0 112.785 -167.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.985 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.719 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HD2' ' HB3' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.751 HG22 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.751 ' HD2' HG22 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG2' HG21 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.995 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.995 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.985 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.665 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.663 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.644 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD2' HG23 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.673 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.646 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.648 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.648 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.618 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.566 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.853 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.516 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.942 HD12 ' HE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.88 ' HD2' HG23 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.942 ' HE ' HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.744 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.673 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB1' ' CD ' ' A' ' 8' ' ' PRO . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.839 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.69 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.911 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.794 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.796 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.796 ' HD2' HG23 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.911 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.639 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.888 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.807 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' HD11 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.944 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.944 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.888 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.683 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.975 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.478 ' HG2' HG22 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.974 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.974 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.975 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.0 t -166.55 -124.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.383 -1.448 . . . . 0.0 111.311 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.65 159.58 34.26 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.937 1.695 . . . . 0.0 112.913 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.663 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.644 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD2' HG23 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.673 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.6 t -165.58 -97.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.939 -1.726 . . . . 0.0 111.58 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -127.76 159.28 35.27 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 126.389 1.876 . . . . 0.0 112.106 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.648 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.648 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.3 t -93.31 -86.87 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.95 -1.719 . . . . 0.0 111.876 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.618 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -144.48 164.69 30.12 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 126.042 1.737 . . . . 0.0 112.558 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.566 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t 69.82 -94.31 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.692 -1.88 . . . . 0.0 111.788 164.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.18 158.72 38.11 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 127.033 2.133 . . . . 0.0 111.953 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.853 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 11.0 t 78.79 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.637 -1.914 . . . . 0.0 112.0 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 169.49 147.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.653 1.581 . . . . 0.0 112.953 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.942 HD12 ' HE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.88 ' HD2' HG23 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.942 ' HE ' HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.744 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 1' ' ' VAL . 10.6 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 9.2 t 50.65 -98.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.61 -1.931 . . . . 0.0 111.215 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . 169.04 158.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.801 1.64 . . . . 0.0 113.046 -173.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.673 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB1' ' CD ' ' A' ' 8' ' ' PRO . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.839 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 t -169.29 -96.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.073 -1.642 . . . . 0.0 112.176 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -129.12 157.71 40.99 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 126.492 1.917 . . . . 0.0 112.141 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.911 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.794 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.796 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.796 ' HD2' HG23 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.911 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.8 t -159.79 -85.76 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.909 0 O-C-N 119.763 -1.836 . . . . 0.0 112.656 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.63 174.86 11.05 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.073 2.149 . . . . 0.0 112.517 -166.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.639 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 1' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 11.2 t 43.71 -108.85 0.13 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.593 -1.942 . . . . 0.0 112.189 167.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' PHE . . . 168.41 132.22 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.109 1.763 . . . . 0.0 112.617 -175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.888 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.807 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' HD11 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.944 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.944 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.888 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t 52.33 -94.48 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.816 0 O-C-N 119.686 -1.884 . . . . 0.0 112.192 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.89 3.44 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.783 1.633 . . . . 0.0 112.785 -167.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.975 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.478 ' HG2' HG22 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.974 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.974 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.975 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.665 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.663 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.644 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD2' HG23 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.673 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.646 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.648 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.648 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.618 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.566 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.853 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' ND1' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.516 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.942 HD12 ' HE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.88 ' HD2' HG23 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.942 ' HE ' HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.744 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.673 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB1' ' CD ' ' A' ' 8' ' ' PRO . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.839 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.69 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.911 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.794 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.796 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.796 ' HD2' HG23 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.911 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 1.715 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.639 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' PHE . . . . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.888 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.807 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' HD11 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.944 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.944 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.888 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 1.683 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.975 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.478 ' HG2' HG22 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.974 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.974 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.975 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.0 t -166.55 -124.51 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.383 -1.448 . . . . 0.0 111.311 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.65 159.58 34.26 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 125.937 1.695 . . . . 0.0 112.913 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.69 100.33 0.1 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 119.841 -1.787 . . . . 0.0 110.991 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.663 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 121.45 17.0 4.06 Favored Glycine 0 CA--C 1.567 3.318 0 O-C-N 120.981 -1.074 . . . . 0.0 112.28 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 20.7 m-85 -138.15 176.3 8.82 Favored 'General case' 0 CA--C 1.568 1.641 0 O-C-N 120.443 -1.622 . . . . 0.0 115.34 -172.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 174.22 165.84 0.33 Allowed Pre-proline 0 CA--C 1.582 2.18 0 O-C-N 120.806 -1.184 . . . . 0.0 112.584 -167.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.85 176.76 0.11 Allowed 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.16 1.907 . . . . 0.0 113.994 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.644 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.381 1.0 OUTLIER -112.87 145.89 33.97 Favored Pre-proline 0 CA--C 1.58 2.115 1 O-C-N 116.297 -4.002 . . . . 0.0 116.341 178.056 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HD2' HG23 ' A' ' 9' ' ' ILE . 31.7 Cg_exo -63.33 98.64 0.22 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 122.273 1.982 . . . . 0.0 114.029 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.48 -12.3 69.04 Favored Glycine 0 CA--C 1.567 3.343 0 O-C-N 116.493 -3.879 . . . . 0.0 111.827 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 90.98 39.98 Favored Pre-proline 0 CA--C 1.581 2.139 0 O-C-N 120.623 -1.516 . . . . 0.0 112.922 173.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.58 37.3 0.47 Allowed 'Trans proline' 0 CA--C 1.572 2.422 0 CA-C-N 122.911 2.075 . . . . 0.0 114.213 -171.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.306 0.0 OUTLIER -108.32 -32.73 7.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 116.332 -3.98 . . . . 0.0 116.529 176.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 172.94 8.56 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 120.298 -1.501 . . . . 0.0 111.547 -174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.2 m -102.36 -160.66 0.8 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 120.303 -1.498 . . . . 0.0 111.268 -166.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.8 pt20 -168.53 -134.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.417 1.487 . . . . 0.0 109.414 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.673 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -96.19 173.73 7.25 Favored 'General case' 0 CA--C 1.578 2.02 0 O-C-N 119.562 -1.962 . . . . 0.0 110.91 161.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 3.5 t80 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.5 2.072 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.6 t -165.58 -97.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.939 -1.726 . . . . 0.0 111.58 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -127.76 159.28 35.27 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 126.389 1.876 . . . . 0.0 112.106 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 94.39 0.56 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 119.668 -1.895 . . . . 0.0 111.052 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.648 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 111.78 24.95 5.05 Favored Glycine 0 CA--C 1.568 3.379 0 O-C-N 120.949 -1.095 . . . . 0.0 111.548 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.571 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 5.0 m-85 -133.41 165.09 25.65 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.437 1.644 . . . . 0.0 115.437 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -165.65 169.81 6.64 Favored Pre-proline 0 CA--C 1.582 2.175 0 O-C-N 120.797 -1.189 . . . . 0.0 112.229 -170.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 28.4 Cg_endo -56.74 178.41 0.14 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 C-N-CA 122.218 1.945 . . . . 0.0 113.821 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.884 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.387 0.8 OUTLIER -113.24 149.2 41.08 Favored Pre-proline 0 CA--C 1.58 2.112 0 O-C-N 116.483 -3.886 . . . . 0.0 115.478 178.214 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HD2' HG23 ' A' ' 9' ' ' ILE . 75.4 Cg_exo -47.14 -64.67 0.23 Allowed 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 123.244 2.194 . . . . 0.0 114.014 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.84 14.73 16.9 Favored Glycine 0 CA--C 1.569 3.411 0 O-C-N 116.452 -3.905 . . . . 0.0 111.141 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 -132.23 70.29 80.16 Favored Pre-proline 0 CA--C 1.582 2.21 0 O-C-N 120.51 -1.583 . . . . 0.0 112.788 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.96 31.84 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.667 0 CA-C-N 123.343 2.23 . . . . 0.0 113.995 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.307 0.1 OUTLIER -94.14 -26.38 16.73 Favored 'General case' 0 N--CA 1.499 2.021 1 O-C-N 116.115 -4.115 . . . . 0.0 115.988 164.414 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -168.15 1.6 Allowed 'General case' 0 CA--C 1.568 1.666 0 O-C-N 120.193 -1.567 . . . . 0.0 111.608 -173.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.2 m -134.82 -178.67 5.19 Favored 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.375 -1.453 . . . . 0.0 111.436 -166.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.4 pt20 -159.44 -135.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 109.432 -166.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -90.8 172.7 8.45 Favored 'General case' 0 CA--C 1.577 2.0 0 O-C-N 119.505 -1.997 . . . . 0.0 110.918 161.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.648 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 20.4 t80 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.3 t -93.31 -86.87 0.25 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.95 -1.719 . . . . 0.0 111.876 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.618 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -144.48 164.69 30.12 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 126.042 1.737 . . . . 0.0 112.558 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.6 86.42 2.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 119.787 -1.821 . . . . 0.0 111.71 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.566 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 118.18 22.05 3.93 Favored Glycine 0 CA--C 1.567 3.316 0 O-C-N 121.213 -0.929 . . . . 0.0 111.475 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 2.6 m-85 -125.89 151.15 47.29 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.76 177.8 1.66 Allowed Pre-proline 0 CA--C 1.582 2.179 0 C-N-CA 124.676 1.191 . . . . 0.0 111.842 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 39.6 Cg_exo -63.52 -160.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.572 2.419 0 CA-C-N 122.508 1.931 . . . . 0.0 114.127 -176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.414 0.4 OUTLIER -122.07 146.23 45.94 Favored Pre-proline 0 CA--C 1.58 2.121 1 O-C-N 116.222 -4.049 . . . . 0.0 115.538 178.048 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 9' ' ' ILE . 35.1 Cg_exo -46.47 -65.29 0.19 Allowed 'Trans proline' 0 CA--C 1.573 2.451 0 CA-C-N 123.164 2.166 . . . . 0.0 114.409 -163.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.83 -3.45 26.69 Favored Glycine 0 CA--C 1.568 3.376 0 O-C-N 116.497 -3.877 . . . . 0.0 111.779 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.64 76.97 64.15 Favored Pre-proline 0 CA--C 1.583 2.227 0 O-C-N 120.498 -1.589 . . . . 0.0 112.572 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -87.51 43.97 0.98 Allowed 'Trans proline' 0 CA--C 1.573 2.44 0 CA-C-N 123.012 2.111 . . . . 0.0 115.269 -163.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.324 0.0 OUTLIER -92.37 -17.46 24.63 Favored 'General case' 0 N--CA 1.499 1.998 1 O-C-N 116.155 -4.09 . . . . 0.0 116.234 166.375 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.13 170.48 11.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.403 -1.436 . . . . 0.0 111.738 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.4 m -99.31 -165.68 1.26 Allowed 'General case' 0 CA--C 1.572 1.817 0 O-C-N 120.34 -1.475 . . . . 0.0 111.178 -167.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 8.2 pt20 -178.21 -132.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.723 1.609 . . . . 0.0 109.131 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 2.9 tt -85.37 174.84 9.26 Favored 'General case' 0 CA--C 1.577 2.003 0 O-C-N 119.308 -2.12 . . . . 0.0 110.961 160.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 15.1 t80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.5 t 69.82 -94.31 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 119.692 -1.88 . . . . 0.0 111.788 164.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.18 158.72 38.11 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 127.033 2.133 . . . . 0.0 111.953 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 94.22 2.61 Favored 'General case' 0 CA--C 1.573 1.832 0 O-C-N 119.679 -1.888 . . . . 0.0 111.857 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.39 16.77 3.07 Favored Glycine 0 CA--C 1.566 3.263 0 O-C-N 121.123 -0.986 . . . . 0.0 112.859 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -122.16 155.51 35.61 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -146.7 165.0 20.99 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 125.468 1.507 . . . . 0.0 111.567 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 40.5 Cg_endo -60.6 -175.91 0.13 Allowed 'Trans proline' 0 CA--C 1.572 2.39 0 CA-C-N 122.694 1.998 . . . . 0.0 114.027 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.853 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.393 1.0 OUTLIER -122.45 145.74 45.47 Favored Pre-proline 0 CA--C 1.579 2.096 0 O-C-N 116.576 -3.828 . . . . 0.0 114.898 178.239 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.853 ' HD2' HG23 ' A' ' 9' ' ' ILE . 71.9 Cg_endo -82.58 -32.83 0.56 Allowed 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 123.947 2.445 . . . . 0.0 114.313 -164.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.54 -27.61 16.98 Favored Glycine 0 CA--C 1.568 3.404 0 O-C-N 116.428 -3.92 . . . . 0.0 110.662 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.94 90.85 25.77 Favored Pre-proline 0 CA--C 1.581 2.162 0 O-C-N 120.658 -1.495 . . . . 0.0 112.869 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.35 30.03 0.54 Allowed 'Trans proline' 0 CA--C 1.578 2.707 0 CA-C-N 123.383 2.244 . . . . 0.0 114.411 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' N ' ' ND1' ' A' ' 14' ' ' HIS 0.318 0.0 OUTLIER -97.0 -9.67 27.75 Favored 'General case' 0 N--CA 1.497 1.878 1 O-C-N 116.14 -4.1 . . . . 0.0 116.29 164.844 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.74 164.15 12.14 Favored 'General case' 0 CA--C 1.569 1.676 0 O-C-N 119.812 -1.805 . . . . 0.0 112.375 -173.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.01 144.27 47.62 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.346 -1.471 . . . . 0.0 111.004 -167.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.0 pt20 -132.83 -146.75 0.28 Allowed 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 124.284 1.034 . . . . 0.0 110.057 -164.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 1.2 mm? -79.04 177.18 9.0 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.978 -1.701 . . . . 0.0 111.44 166.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 11.0 t 78.79 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.637 -1.914 . . . . 0.0 112.0 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 2' ' ' CYS . . . 169.49 147.67 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.653 1.581 . . . . 0.0 112.953 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.17 100.73 0.24 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.729 -1.857 . . . . 0.0 111.133 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 133.47 6.06 2.77 Favored Glycine 0 CA--C 1.568 3.366 0 O-C-N 121.132 -0.98 . . . . 0.0 113.297 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' A' ' 5' ' ' GLY . 1.7 m-85 -128.59 161.87 28.61 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -151.94 165.79 16.68 Favored Pre-proline 0 CA--C 1.582 2.208 0 C-N-CA 124.87 1.268 . . . . 0.0 111.72 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.615 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 30.8 Cg_endo -57.07 178.13 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.558 1.949 . . . . 0.0 113.263 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.942 HD12 ' HE ' ' A' ' 15' ' ' ARG 0.408 1.1 mt -112.07 145.69 33.3 Favored Pre-proline 0 CA--C 1.581 2.158 0 O-C-N 116.645 -3.784 . . . . 0.0 114.887 178.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.88 ' HD2' HG23 ' A' ' 9' ' ' ILE . 22.9 Cg_exo -43.75 -41.0 11.5 Favored 'Trans proline' 0 CA--C 1.571 2.361 0 C-N-CA 122.927 2.418 . . . . 0.0 116.019 -163.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.13 9.53 7.03 Favored Glycine 0 CA--C 1.567 3.339 0 O-C-N 116.36 -3.962 . . . . 0.0 112.356 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 79.37 11.91 Favored Pre-proline 0 CA--C 1.581 2.159 0 O-C-N 120.591 -1.535 . . . . 0.0 112.8 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -80.25 31.7 0.49 Allowed 'Trans proline' 0 CA--C 1.577 2.668 0 CA-C-N 122.831 2.047 . . . . 0.0 114.076 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.309 0.1 OUTLIER -93.69 -23.35 18.26 Favored 'General case' 0 N--CA 1.499 1.984 1 O-C-N 116.088 -4.132 . . . . 0.0 115.884 163.042 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.942 ' HE ' HD12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.85 -170.77 1.98 Allowed 'General case' 0 CA--C 1.569 1.676 0 O-C-N 120.224 -1.548 . . . . 0.0 111.224 176.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -145.24 157.62 44.02 Favored 'General case' 0 CA--C 1.571 1.77 0 O-C-N 120.31 -1.494 . . . . 0.0 111.796 -163.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.744 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 2.6 pt20 -141.41 -146.23 0.19 Allowed 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 125.392 1.477 . . . . 0.0 109.787 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.744 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.5 OUTLIER -78.97 174.86 11.11 Favored 'General case' 0 CA--C 1.577 1.985 0 O-C-N 119.833 -1.792 . . . . 0.0 111.098 162.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 6.2 t80 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 1' ' ' VAL . 10.6 p . . . . . 0 N--CA 1.501 2.124 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 9.2 t 50.65 -98.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 119.61 -1.931 . . . . 0.0 111.215 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.673 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . 169.04 158.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.801 1.64 . . . . 0.0 113.046 -173.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 95.96 3.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.861 -1.774 . . . . 0.0 111.716 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . 114.66 24.46 4.33 Favored Glycine 0 CA--C 1.567 3.283 0 O-C-N 121.028 -1.045 . . . . 0.0 111.749 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.673 ' CG ' ' HB3' ' A' ' 3' ' ' ALA . 4.9 m-85 -122.22 164.75 17.3 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HB1' ' CD ' ' A' ' 8' ' ' PRO . . . -151.99 -175.56 0.5 Allowed Pre-proline 0 CA--C 1.58 2.125 0 O-C-N 120.7 -1.25 . . . . 0.0 111.791 -167.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.591 ' CD ' ' HB1' ' A' ' 7' ' ' ALA . 4.6 Cg_endo -81.7 -167.9 0.55 Allowed 'Trans proline' 0 CA--C 1.573 2.446 0 C-N-CA 122.573 2.182 . . . . 0.0 113.571 -176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.839 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.375 1.1 mt -112.98 145.18 32.55 Favored Pre-proline 0 CA--C 1.58 2.132 0 O-C-N 116.519 -3.863 . . . . 0.0 115.397 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.839 ' HD2' HG23 ' A' ' 9' ' ' ILE . 77.6 Cg_exo -50.1 -64.71 0.19 Allowed 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 123.034 2.119 . . . . 0.0 114.035 -173.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.6 5.66 31.29 Favored Glycine 0 CA--C 1.568 3.383 0 O-C-N 116.418 -3.926 . . . . 0.0 111.745 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -128.55 71.12 80.48 Favored Pre-proline 0 CA--C 1.583 2.22 0 O-C-N 120.431 -1.629 . . . . 0.0 112.792 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.69 39.08 0.72 Allowed 'Trans proline' 0 CA--C 1.573 2.474 0 CA-C-N 123.505 2.288 . . . . 0.0 115.22 -163.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.287 0.0 OUTLIER -94.69 -33.31 12.99 Favored 'General case' 0 N--CA 1.497 1.88 1 O-C-N 115.923 -4.236 . . . . 0.0 116.425 164.846 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.2 170.52 8.16 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 120.232 -1.542 . . . . 0.0 112.344 -172.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.3 m -103.45 -169.43 1.64 Allowed 'General case' 0 CA--C 1.573 1.833 0 O-C-N 120.387 -1.445 . . . . 0.0 111.321 -166.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -175.04 -125.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.647 1.579 . . . . 0.0 109.113 -165.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -94.72 175.87 6.49 Favored 'General case' 0 CA--C 1.582 2.203 0 O-C-N 119.213 -2.179 . . . . 0.0 110.417 158.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.1 t -169.29 -96.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.073 -1.642 . . . . 0.0 112.176 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.499 ' HB3' ' CG ' ' A' ' 6' ' ' PHE . . . -129.12 157.71 40.99 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 126.492 1.917 . . . . 0.0 112.141 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -69.04 89.91 0.44 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.834 -1.792 . . . . 0.0 111.606 176.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.911 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 115.47 28.12 2.88 Favored Glycine 0 CA--C 1.567 3.321 0 O-C-N 120.708 -1.245 . . . . 0.0 111.189 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.794 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 16.1 m-85 -134.88 148.55 50.13 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' O ' ' HG2' ' A' ' 17' ' ' GLN . . . -144.89 147.59 35.72 Favored Pre-proline 0 CA--C 1.582 2.205 0 C-N-CA 124.544 1.138 . . . . 0.0 111.803 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -55.41 176.74 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 122.599 1.964 . . . . 0.0 113.522 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.796 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.383 1.5 mt -112.11 144.02 29.93 Favored Pre-proline 0 CA--C 1.581 2.169 0 O-C-N 116.508 -3.87 . . . . 0.0 115.663 177.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.796 ' HD2' HG23 ' A' ' 9' ' ' ILE . 53.2 Cg_exo -55.52 -33.57 86.86 Favored 'Trans proline' 0 CA--C 1.572 2.425 0 CA-C-N 122.781 2.029 . . . . 0.0 114.951 -164.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.93 -26.63 1.22 Allowed Glycine 0 CA--C 1.568 3.355 0 O-C-N 116.503 -3.873 . . . . 0.0 112.495 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.71 92.01 49.29 Favored Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 120.65 -1.5 . . . . 0.0 112.618 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.81 37.38 0.61 Allowed 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.895 2.069 . . . . 0.0 114.306 -167.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.312 0.1 OUTLIER -104.55 -17.98 14.52 Favored 'General case' 0 N--CA 1.495 1.807 1 O-C-N 116.288 -4.007 . . . . 0.0 116.293 175.843 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -98.56 72.01 2.01 Favored 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.519 -1.363 . . . . 0.0 111.208 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.09 118.32 3.13 Favored 'General case' 0 CA--C 1.572 1.809 0 O-C-N 120.529 -1.357 . . . . 0.0 110.934 -167.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 7' ' ' ALA . 3.8 pt20 -82.77 -141.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.985 0.914 . . . . 0.0 109.475 -163.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -85.81 172.88 10.44 Favored 'General case' 0 CA--C 1.576 1.954 0 O-C-N 119.741 -1.849 . . . . 0.0 111.051 162.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.911 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 2.3 t80 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 52.8 t -159.79 -85.76 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.909 0 O-C-N 119.763 -1.836 . . . . 0.0 112.656 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.63 174.86 11.05 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.073 2.149 . . . . 0.0 112.517 -166.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.87 90.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.112 -1.618 . . . . 0.0 112.142 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.24 32.77 1.44 Allowed Glycine 0 CA--C 1.568 3.37 0 O-C-N 120.6 -1.312 . . . . 0.0 110.571 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.639 ' N ' ' HB2' ' A' ' 19' ' ' PHE . 88.2 m-85 -146.04 142.6 28.76 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -134.17 167.51 22.47 Favored Pre-proline 0 CA--C 1.585 2.3 0 C-N-CA 125.576 1.55 . . . . 0.0 111.169 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 24.8 Cg_endo -55.72 173.99 0.33 Allowed 'Trans proline' 0 CA--C 1.571 2.331 0 CA-C-N 122.999 2.107 . . . . 0.0 113.391 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 0.6 OUTLIER -115.3 143.52 30.52 Favored Pre-proline 0 CA--C 1.58 2.116 0 O-C-N 116.516 -3.865 . . . . 0.0 115.765 178.522 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 9' ' ' ILE . 72.6 Cg_exo -54.05 -64.34 0.17 Allowed 'Trans proline' 0 CA--C 1.572 2.4 0 CA-C-N 123.061 2.129 . . . . 0.0 114.261 -169.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.61 11.57 50.25 Favored Glycine 0 CA--C 1.568 3.394 0 O-C-N 116.404 -3.935 . . . . 0.0 112.087 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.32 76.8 42.9 Favored Pre-proline 0 CA--C 1.583 2.214 0 O-C-N 120.578 -1.543 . . . . 0.0 112.707 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.89 29.8 0.44 Allowed 'Trans proline' 0 CA--C 1.579 2.756 0 CA-C-N 122.819 2.042 . . . . 0.0 113.892 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.301 0.0 OUTLIER -95.48 -33.52 12.41 Favored 'General case' 0 N--CA 1.5 2.033 1 O-C-N 116.054 -4.154 . . . . 0.0 115.678 163.01 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.26 -164.03 1.11 Allowed 'General case' 0 CA--C 1.571 1.767 0 O-C-N 119.677 -1.89 . . . . 0.0 111.916 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 29.9 p -167.02 147.19 5.54 Favored 'General case' 0 CA--C 1.575 1.905 0 O-C-N 120.413 -1.429 . . . . 0.0 110.758 -167.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 6' ' ' PHE . 12.6 pt20 -112.4 -122.72 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.766 1.626 . . . . 0.0 110.296 -162.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 ' N ' ' HG3' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -100.69 137.86 38.52 Favored 'General case' 0 CA--C 1.576 1.972 0 O-C-N 119.333 -2.104 . . . . 0.0 110.17 162.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB2' ' N ' ' A' ' 6' ' ' PHE . 31.9 t80 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.54 ' O ' HG12 ' A' ' 1' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 11.2 t 43.71 -108.85 0.13 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 119.593 -1.942 . . . . 0.0 112.189 167.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.593 ' HB3' ' CD1' ' A' ' 6' ' ' PHE . . . 168.41 132.22 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.109 1.763 . . . . 0.0 112.617 -175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.16 93.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 119.685 -1.884 . . . . 0.0 111.125 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.888 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 120.59 25.27 2.41 Favored Glycine 0 CA--C 1.568 3.359 0 O-C-N 120.88 -1.138 . . . . 0.0 111.71 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 3' ' ' ALA . 34.0 m-85 -137.18 155.17 49.88 Favored 'General case' 0 CA--C 1.568 1.656 0 O-C-N 120.498 -1.589 . . . . 0.0 114.938 -172.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.748 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -158.64 173.4 5.02 Favored Pre-proline 0 CA--C 1.583 2.231 0 O-C-N 120.842 -1.161 . . . . 0.0 112.19 -164.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.748 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 19.2 Cg_endo -62.89 -173.74 0.16 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 122.331 2.021 . . . . 0.0 114.069 -166.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.807 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.397 2.7 mt -122.47 145.27 44.24 Favored Pre-proline 0 CA--C 1.58 2.134 1 O-C-N 116.261 -4.024 . . . . 0.0 116.594 178.535 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.807 ' HD2' HG23 ' A' ' 9' ' ' ILE . 60.7 Cg_exo -56.95 -19.22 31.23 Favored 'Trans proline' 0 CA--C 1.571 2.347 0 C-N-CA 122.176 1.917 . . . . 0.0 114.654 -165.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.72 -24.01 0.11 Allowed Glycine 0 CA--C 1.567 3.326 0 O-C-N 116.476 -3.89 . . . . 0.0 112.72 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.51 84.83 6.64 Favored Pre-proline 0 CA--C 1.583 2.212 0 O-C-N 120.595 -1.532 . . . . 0.0 112.57 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.48 39.63 0.58 Allowed 'Trans proline' 0 CA--C 1.572 2.389 0 CA-C-N 122.841 2.051 . . . . 0.0 114.863 -163.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.3 0.2 OUTLIER -92.42 -40.94 10.59 Favored 'General case' 0 N--CA 1.497 1.882 1 O-C-N 116.261 -4.024 . . . . 0.0 116.032 171.211 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.09 160.4 21.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.453 -1.404 . . . . 0.0 111.668 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' HD11 ' A' ' 9' ' ' ILE . 24.8 m -88.96 -157.67 0.45 Allowed 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.553 -1.342 . . . . 0.0 111.461 -166.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.944 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -171.44 -57.97 0.02 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 125.089 1.356 . . . . 0.0 109.8 -173.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.944 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 6.9 mt -160.75 177.93 9.95 Favored 'General case' 0 CA--C 1.577 2.014 0 O-C-N 120.404 -1.435 . . . . 0.0 111.44 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.888 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.7 t 52.33 -94.48 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.816 0 O-C-N 119.686 -1.884 . . . . 0.0 112.192 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.78 169.89 3.44 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 125.783 1.633 . . . . 0.0 112.785 -167.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -66.23 118.73 10.35 Favored 'General case' 0 CA--C 1.573 1.851 0 O-C-N 119.833 -1.792 . . . . 0.0 111.772 176.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.975 ' C ' ' HB2' ' A' ' 19' ' ' PHE . . . 87.56 30.8 17.68 Favored Glycine 0 CA--C 1.565 3.218 0 C-N-CA 124.609 1.1 . . . . 0.0 114.098 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -135.85 149.4 49.03 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 8' ' ' PRO . . . -144.55 171.2 6.97 Favored Pre-proline 0 CA--C 1.581 2.153 0 O-C-N 120.874 -1.141 . . . . 0.0 112.205 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 7' ' ' ALA . 42.0 Cg_endo -61.64 -178.12 0.27 Allowed 'Trans proline' 0 CA--C 1.571 2.341 0 C-N-CA 122.251 1.967 . . . . 0.0 114.094 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 10' ' ' PRO 0.391 1.4 mt -123.91 150.05 61.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 116.45 -3.906 . . . . 0.0 116.403 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 9' ' ' ILE . 11.5 Cg_exo -71.14 97.2 0.74 Allowed 'Trans proline' 0 CA--C 1.573 2.456 0 CA-C-N 122.822 2.044 . . . . 0.0 114.27 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.39 -21.17 45.43 Favored Glycine 0 CA--C 1.568 3.367 0 O-C-N 116.523 -3.86 . . . . 0.0 112.469 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.478 ' HG2' HG22 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -129.31 83.45 65.35 Favored Pre-proline 0 CA--C 1.582 2.182 0 O-C-N 120.683 -1.481 . . . . 0.0 112.888 174.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.88 37.06 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.51 0 C-N-CA 122.653 2.236 . . . . 0.0 113.918 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . 0.322 0.0 OUTLIER -101.46 -40.16 7.2 Favored 'General case' 0 N--CA 1.495 1.787 1 O-C-N 116.183 -4.073 . . . . 0.0 116.275 175.151 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 173.24 6.68 Favored 'General case' 0 CA--C 1.57 1.729 0 O-C-N 120.429 -1.419 . . . . 0.0 112.167 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -178.23 3.55 Favored 'General case' 0 CA--C 1.573 1.83 0 O-C-N 120.507 -1.371 . . . . 0.0 111.501 -165.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.974 ' HG2' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -147.86 -52.55 0.19 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 125.525 1.53 . . . . 0.0 109.978 -163.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.974 ' N ' ' HG2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -165.27 177.44 7.6 Favored 'General case' 0 CA--C 1.577 1.981 0 O-C-N 120.427 -1.421 . . . . 0.0 111.503 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.975 ' HB2' ' C ' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 174.796 . . . . . . . . 2 2 . 1 stop_ save_